HMGCR and non-small cell lung carcinoma: Collectively, these results show that human NSCLC cells harbouring different genetic mutations are susceptible to statin-induced cell death in vitro, which is mediated by blocking the mevalonate pathway through inhibition of HMG-CoA reductase.